A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Clinical trial NCT03526835 · RECRUITING

Trial details

NCT number: NCT03526835
Sponsor: Merus B.V.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced/Metastatic Solid Tumors Colorectal Cancer Gastric Cancer Gastroesophageal-junction Cancer NSCLC HNSCC Head and Neck Squamous Cell Carcinoma Esophageal Cancer

Start date: 2018-05-02
Primary completion: 2028-05-01
Enrollment: 560

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.